嘉应制药
(002198)
| 流通市值：33.19亿 | | | 总市值：33.19亿 |
| 流通股本：5.07亿 | | | 总股本：5.08亿 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 127,892,923.27 | 201,259,933.75 | 264,960,176.44 | 336,141,154.38 |
| 交易性金融资产 | 12,294 | 4,793,858 | 3,490,376 | - |
| 应收票据及应收账款 | 140,874,326.42 | 152,178,953.16 | 159,322,251.66 | 106,449,472.04 |
| 其中：应收票据 | 5,177,534.75 | 15,167,699.94 | 27,751,144.43 | 29,457,997.77 |
| 应收账款 | 135,696,791.67 | 137,011,253.22 | 131,571,107.23 | 76,991,474.27 |
| 应收款项融资 | 10,062,000.44 | 5,386,262.85 | 24,274,557.59 | 22,477,878.29 |
| 预付款项 | 78,816,564.06 | 8,501,725.31 | 1,011,340.51 | 1,634,160.12 |
| 其他应收款合计 | 22,809,716.16 | 23,125,463.97 | 1,083,268.07 | 1,161,007.24 |
| 存货 | 85,390,635.05 | 83,077,412.75 | 74,294,875.18 | 85,061,270.13 |
| 其他流动资产 | 249,780.94 | 222,586.9 | 908,765.57 | 833,422.06 |
| 流动资产合计 | 466,108,240.34 | 478,546,196.69 | 529,345,611.02 | 553,758,364.26 |
| 非流动资产: | | | | |
| 长期股权投资 | 41,366,643.25 | 42,246,684.98 | 22,897,065.05 | 23,303,717.52 |
| 固定资产 | 170,079,391.32 | 173,907,874.01 | 176,450,771.13 | 180,951,372.14 |
| 在建工程 | 35,068,391.6 | 32,803,701.85 | 31,340,384.36 | 29,056,017.97 |
| 无形资产 | 46,696,449.97 | 47,125,549.11 | 45,587,895.55 | 45,891,040.66 |
| 开发支出 | 8,927,358.49 | 8,927,358.49 | - | - |
| 长期待摊费用 | 1,836,939.22 | 2,521,272.07 | 1,697,496.71 | 1,401,315.26 |
| 递延所得税资产 | 4,642,986.26 | 4,642,986.26 | 3,027,430.27 | 3,029,863.9 |
| 其他非流动资产 | - | - | 2,289,264 | 1,428,760 |
| 非流动资产合计 | 308,618,160.11 | 312,175,426.77 | 283,290,307.07 | 285,062,087.45 |
| 资产总计 | 774,726,400.45 | 790,721,623.46 | 812,635,918.09 | 838,820,451.71 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 9,714,818.31 | 11,827,778.13 | 11,606,617.68 | 12,607,576.55 |
| 应付账款 | 9,714,818.31 | 11,827,778.13 | 11,606,617.68 | 12,607,576.55 |
| 合同负债 | 2,735,503.97 | 2,778,145.49 | 1,926,390.4 | 2,879,914.51 |
| 应付职工薪酬 | 4,363,864.09 | 4,910,106.65 | 3,216,546.7 | 4,771,083.19 |
| 应交税费 | 6,496,551.52 | 4,651,834.6 | 13,395,298.92 | 6,889,321.14 |
| 其他应付款合计 | 6,204,470.05 | 6,028,893.78 | 23,089,725.27 | 14,868,696.72 |
| 其他流动负债 | 1,248,906.79 | 9,608,667.71 | 250,430.76 | 3,548,773.85 |
| 流动负债合计 | 30,764,114.73 | 39,805,426.36 | 53,485,009.73 | 45,565,365.96 |
| 非流动负债: | | | | |
| 递延收益 | 207,154.73 | 230,268.29 | 256,156.72 | 287,594.89 |
| 递延所得税负债 | 34,746,735.76 | 34,746,735.76 | 34,746,735.76 | 34,746,735.76 |
| 非流动负债合计 | 34,953,890.49 | 34,977,004.05 | 35,002,892.48 | 35,034,330.65 |
| 负债合计 | 65,718,005.22 | 74,782,430.41 | 88,487,902.21 | 80,599,696.61 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 507,509,848 | 507,509,848 | 507,509,848 | 507,509,848 |
| 资本公积 | 123,652,931.39 | 123,652,931.39 | 123,652,931.39 | 123,652,931.39 |
| 减:库存股 | 69,995,657.57 | 61,301,621.53 | 49,475,996.4 | - |
| 其他综合收益 | -1,011,000 | -1,062,500 | - | - |
| 盈余公积 | 27,767,450.89 | 27,767,450.89 | 27,767,450.89 | 27,767,450.89 |
| 未分配利润 | 121,084,822.52 | 119,373,084.3 | 114,693,782 | 99,290,524.82 |
| 归属于母公司股东权益合计 | 709,008,395.23 | 715,939,193.05 | 724,148,015.88 | 758,220,755.1 |
| 股东权益合计 | 709,008,395.23 | 715,939,193.05 | 724,148,015.88 | 758,220,755.1 |
| 负债和股东权益合计 | 774,726,400.45 | 790,721,623.46 | 812,635,918.09 | 838,820,451.71 |
| 公告日期 | 2025-10-29 | 2025-08-26 | 2025-04-26 | 2025-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |